Daiichi Sankyo Co Ltd at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. Welcome to the JPMorgan Healthcare Conference. I'm Seiji Wakao, Japan pharma Analyst, JPMorgan. And it's my pleasure to introduce Manabe-san, CEO of Daiichi Sankyo and welcome him to the conference.
Let me turn it over to Manabe-san. Manabe-san, please go ahead.
Thank you, Wakao-san. My name is Sunao Manabe, CEO of Daiichi Sankyo. Hello, colleagues. Thank you for showing interest in Daiichi Sankyo. Also, I'd like to thank JPMorgan for giving me as this opportunity. It was a great experience for me to participate in last year JPMorgan Conference. Then I am very happy to be here again.
Let's go to Page 3. Today, I'll begin by providing a brief overview of Daiichi Sankyo. Then I will present our ADCs focusing on our 5 lead products, and I will take you through our latest R&D strategy. And lastly, I will cover our shareholder returns.
Go to Page 4. Daiichi
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |